At CD BioGlyco, we continue to promote the integration and innovation of glycobiology and information technology. Starting from the basic Glycoinformatics-assisted Glycomics Analysis Services, we gradually deepen our service areas. First, we expand to a wider range of disease research and provide Glycoinformatics-assisted Disease Glycomics Analysis Service, which aims to comprehensively analyze the dynamic changes of glycomics in disease states. Then, we specially create Glycoinformatics-assisted Cancer Glycomics Analysis Services, which focuses on cancer-related glycomics research.
Here, we proudly offer analysis of glycosylation changes in cancer, which uses our glycoinformatics platform, combined with high-precision mass spectrometry (MS) technology, to deeply explore and analyze the subtle details of glycosylation changes during the development of cancer.
We begin by obtaining high-quality biological samples from clients, which may include tissue, blood samples, or cultured cells. Our experienced team employs advanced techniques such as MS and liquid chromatography (LC) to accurately identify and quantify glycan structures.
Using our glycan profiling techniques, we comprehensively characterize the glycan structures present in the samples. This includes identifying the monosaccharide composition, glycosidic linkages, branching patterns, and any modifications like sialylation, fucosylation, or sulfation.
Our specialized glycoinformatics platform integrates high-throughput data analysis with curated glycan databases. This involves:
Data integration: Aggregating and normalizing data from various high-throughput platforms, ensuring consistency and accuracy.
Pathway mapping: Mapping glycosylation changes onto known metabolic and signaling pathways to decipher their biological significance.
To identify cancer-specific glycosylation changes, we perform comparative glycomics by contrasting the glycan profiles of cancerous samples with normal or benign tissues. This differential analysis highlights unique glycosylation signatures that may serve as potential biomarkers for cancer detection and prognosis.
We explore the functional implications of identified glycosylation changes. This includes:
Assessing the impact on protein folding, stability, and interactions.
Evaluating the potential for immune system evasion via altered glycan motifs.
Investigating any influence on cell signaling pathways and adhesion properties.
Our final step involves delivering a comprehensive report that includes detailed glycan structures, statistical analyses, pathway implications, and potential biomarkers. We also offer personalized consultation sessions to discuss findings and recommend further experimental validation or therapeutic exploration.
Journal: International Journal of Molecular Sciences
IF: 4.9
Published: 2020
Results: The authors consolidated the available tools and their applications in glycosylation research. They presented the achievements made through the use of bioinformatics in glycosylation studies. Additionally, the authors discussed the importance of glycosylation in cancer diagnosis and therapy, highlighting the gap in the application of widely available glyco-informatic tools for cancer research.
Fig.1 Summary of the key features of glycosylation in cancer. (Muthu, et al., 2020)
At CD BioGlyco, we are dedicated to advancing cancer research through innovative glycomic solutions. Our analysis of glycosylation changes in cancer offers unparalleled precision and insight into the complex world of cancer glycosylation. Please feel free to contact us if you are interested in our analysis of glycosylation changes in cancer.
Reference
We envision a future where the intricate world of carbohydrate is no longer shrouded in mystery, but rather illuminated by the power of cutting-edge computational tools.